independently classify research projects by: (i) disease site using the International Cancer Research Partnership classification; [9] and (ii) scientific domain (basic, clinical and public health research). Project titles suggesting that the research was aimed at understanding fundamental biological systems were classified as basic science research; those suggesting that the research was conducted with human subjects or on material of human origin such as tissues, and for which it was likely that an investigator directly interacted with human subjects, were classified as clinical research; and research conducted at a population or organisational level, including health system research, environmental and occupational research or patient perspectives, was classified as public health research. Projects could be classified into more than one scientific domain. A more detailed analysis was conducted for the five most common male and female cancers diagnosed in SA, using an adaption of the Common Scientific Outline (CSO) classification system. [10] The CSO classification is organised around six broad areas of scientific interest in cancer research, viz.: (i) biology; (ii) aetiology; (iii) prevention; (iv) early detection, diag nosis, and prognosis; (v) treatment; and (vi) cancer control, survivorship, and out comes research, and is used to discuss, compare and present cancer research portfolios. For our analysis we expanded the CSO categories into nine categories to provide more detail. The expanded adapted CSO categories were: (i) biology; (ii) aetiology; (iii) prevention; (iv) early detection and diagnosis; (v) clinical prognosis/progression; (vi) treatment; (vii) clinical audits; (viii) survivor ship; and (ix) patient perspectives. Research activity in the five most commonly diagnosed male and female cancers in SA was assessed. The most common cancers were identified using cancer incidence data from the SA National Cancer Registry. [2] 
Results
Fifteen of the 29 institutions (52%) res ponded directly, and infor mation on an additional six institutions was obtained indirectly through responses from three SA organisations that fund cancer research, viz. the South African Medical Research Council, the National Research Foundation and the Cancer Association of South Africa. In total, these institutions provided information on 757 projects. Projects that were completed before 2013 (n=110), duplicate projects submitted by both research funding agencies and recipient institutions (n=38) and non research projects (n=53) were removed, leaving a total of 556 projects for analysis.
Scientific domain and disease site
Overall, 301 projects were classified as clini cal, 254 as basic science and 71 as public health research (Fig. 1 ). The majority of projects (n=392) focused on a single disease site, 18 projects addressed multiple sites and 146 were nonsitespecific. The five most common cancers being researched were cancers of the breast (n=95 projects) and cervix (n=43), leukaemia (n=36), non Hodgkin's lymphoma (n=35) and lung cancer (n=23). There were 29 paediatric cancer projects, with the vast majority (n=24) classified as addressing clinical research. The majority of sitespecific paediatric cancer research projects were on leukaemia (n=4) and lymphomas (n=4). The 556 projects included 95 clinical trials, with 64 being phase III clinical trials. The majority of clinical trials were related to breast cancer (n=22), leukaemia (n=15) and lung cancer (n=14). There were no costing or costeffectiveness studies.
Research on the most common cancers diagnosed in SA
A total of 164 projects addressed the five most common cancers diagnosed in women in SA (Fig. 2) . Overall, clinical research was the most common type of research being conducted and public health research the least common. In contrast, for cervical cancer there were a similar number of research projects across all three scientific domains (i.e. basic science, clinical and public health). Classification using the adapted CSO categories (Table 1) showed that the majority of projects were related to treatment, with relatively few projects on survivorship and patient behaviour.
A total of 72 projects addressed the five most common cancers in males (Fig. 3) . The majority of the projects were related to clinical research (n=42), with relatively few (n=7) addressing public health issues. Projects on lung cancer dominated, and according to CSO categorisation ( Table 1 ) the majority of these were treatmentrelated projects. There were no projects being conducted on survivorship, and there was one project on prevention of cancer and two projects addressing patient perspectives.
Discussion
In an effort to understand whether current research addresses the burden of cancer in SA, academic and research organisations in the country were contacted for information on current and recently completed cancer research. Our findings established that there is a dearth of public health research. In a resource limited setting such as SA, public health cancer research offers many opportunities to address the cancer burden. For example, research that identifies reasons for late presentation, supports early diagnosis, identifies costeffective management, improves the efficiency and effectiveness of cancer management and improves the quality of life of individuals with cancer will be particularly useful in informing local cancer policies and guidelines. It is of concern that there were no costing or costeffectiveness cancer research projects. However, it is possible that deskbased economic studies that did not require ethical approval could inadvertently have been excluded from the list of projects submitted by institutions. In the SA context, economic studies could be invaluable in guiding diagnosis, treatment and prevention options as well as decisions on resource allocation. Public health cancer research could be limited as a result of lack of requisite research skills and/or limited funding for such research. This needs further investigation. Previous reports have highlighted the mismatch between the disease burden in developing countries and the human capacity to generate relevant new knowledge, [11, 12] and there have been calls to strengthen the health research capacity in the country. It is important that initiatives aimed at increasing research capacity are directed at priority health problems such as cancer, and that the gap in public health cancer research is addressed.
Breast cancer is the most common cancer diagnosed in women in SA, with an agestandardised incidence rate of 27 per 100 000; however, in several regions in the country cervical cancer remains the most common cancer. [2] It is encouraging that current research on female cancers focuses on the two most common cancers 
Study limitations
There were several limitations in our approach to determining current cancer research, and the results need to be interpreted with this in mind. Firstly, only 52% of institutions contacted responded. However, the institutions in SA known to have a high research influence did provide information on their cancer research portfolios. [13] Although each project was classified by more than one team member, information on project aims and objectives was unavailable, so classification by scientific domain and the expanded CSO categories was challenging and subject to misclassification. This review did not assess the quality of the research or review past cancer research. Further discussions on the challenges faced by local cancer researchers and funding agencies, the influence of local research on policies and guidelines and the extent to which research addresses the specific needs of the country are required to understand the SA cancer research landscape fully. The SA Medical Research Council is well placed to facilitate such discussions and future assessments.
Conclusion
Research is key to addressing the cancer burden in SA. This review highlighted the need for a cancer research registry that will provide ongoing information on the state of cancer research in the country, enable assessment of the relevance of such research, and assist in identifying research and funding priorities.
